• Biology, Medicine
  • Published in Frontiers in bioscience 2011
  • DOI:10.2741/3850

Dramatic improvement of DC-based immunotherapy against various malignancies.

@article{Harada2011DramaticIO,
  title={Dramatic improvement of DC-based immunotherapy against various malignancies.},
  author={Yui Harada and Yoshikazu Yonemitsu},
  journal={Frontiers in bioscience},
  year={2011},
  volume={16},
  pages={
          2233-42
        }
}
Dendritic cells (DCs) play a crucial role in maintaining the immune system. Though DC-based cancer immunotherapy has been suggested as a potential treatment for various kinds of malignancies, clinical efficacies are still insufficient in many human trials. To identify the causes of the low efficacies, we paid attention to their numbers and how they are activated. We proved that DCs' antitumor effect depends on their number and the way they are activated. We here established a possible… CONTINUE READING

Figures and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 65 REFERENCES

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.

  • Lin Zhou, Thomas F. Tedder
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 1996
VIEW 10 EXCERPTS
HIGHLY INFLUENTIAL

Proliferating dendritic cell progenitors in human blood

VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL